Advanced semen analysis: a simple screening test to predict intrauterine insemination success
|
|
- Sherman Miller
- 5 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY VOL. 71, NO. 3, MARCH 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Advanced semen analysis: a simple screening test to predict intrauterine insemination success Emmett F. Branigan, M.D.,* M. Antoinette Estes, B.S.,* and Charles H. Muller, Ph.D. Bellingham In Vitro Fertilization and Infertility Center, Bellingham, and Department of Urology, University of Washington School of Medicine, Seattle, Washington Received June 9, 1998; revised and accepted November 10, Presented at the 46th Annual Meeting of the Pacific Coast Fertility Society, Indian Wells, California, April 22 26, Reprint requests: Emmett F. Branigan, M.D., 2980 Squalicum, Parkway 103, Bellingham, Washington (FAX: ). * Bellingham In Vitro Fertilization and Infertility Center. Department of Urology, University of Washington School of Medicine /99/$20.00 PII S (98) Objective: To determine if a simple screening test of sperm recovery through a density gradient preparation and sperm survival after a 24-hour incubation is predictive of IUI success. Design: Prospective nonrandomized descriptive study. Setting: Tertiary assisted reproductive technology center. Patient(s): Four hundred fourteen couples undergoing IUI for male factor and unexplained infertility. Intervention(s): An advanced semen analysis, which consisted of a basic semen analysis, sperm processing through a density gradient preparation, and a 24-hour sperm incubation, was performed on all couples before beginning IUIs. Main Outcome Measure(s): Cumulative and per cycle pregnancy rates (PRs) were calculated for routine semen parameters, number of sperm processed through density gradient, and percent motile sperm after a 24-hour incubation. Result(s): None of the basic semen analysis parameters accurately predicted IUI success. When the processed total motile sperm available for insemination was and their 24-hour survival was 70%, 89% (162 of 182) of couples achieved a pregnancy with a 21.4% (162 of 757) per cycle PR compared to a 2.8% (11 of 403) per cycle PR and 4.7% total PR when survival was 70%. With use of these cutoff values for the advanced semen analysis, the test had a sensitivity of 94% and specificity of 86%. Conclusion(s): The number of motile sperm available for insemination and especially their 24-hour survival are highly predictive of IUI success. This advanced semen analysis is an excellent screening test to evaluate couples considering IUI. (Fertil Steril 1999;71: by American Society for Reproductive Medicine.) Key Words: Advanced semen analysis, density gradient, sperm survival, screening test, intrauterine insemination Intrauterine insemination offers a simple, less expensive, and more acceptable treatment for male factor problems than other advanced reproductive technology procedures. However, the usefulness of IUIs for treating male factor problems remains controversial. The problem is that there is no test or set of tests that is predictive of those likely to benefit from IUIs. Basic semen analysis and even advanced sperm function testing are poor predictors of IUI success, unless severe problems are present (1, 2). Because there are no screening tests to evaluate those likely to benefit from IUIs, most doctors and clinics will often use an empiric trial of three to six or more IUI cycles before moving on to other forms of treatment (3 5). As a result of this, the patients treated using IUIs are a heterogeneous group. Differences in sperm preparations used, insemination techniques, and the use of ovulation induction agents also make studies comparing the effectiveness of IUIs difficult. We developed a potential screening test we call an Advanced Semen Analysis. This test includes a basic semen analysis, followed by a density gradient sperm separation to determine the processed motile sperm fraction and a 24- hour incubation to assess sperm survival. This test measures more dynamic aspects of sperm function than the basic semen analysis. Two important physiologic properties of sperm necessary for insemination success are the number 547
2 of highly motile sperm in a sample and the longevity or survivability of those sperm. Several studies showed that total motile sperm are an important factor for IUI success (1, 5, 6). Processed total motile sperm through a density gradient preparation selects a sperm population with a better motility and morphology index than calculated total motile sperm counts (3, 7). However, because the time between when the insemination is performed relative to oocyte release is variable, sperm survival may be a more important characteristic. The objective of this study is to determine if sperm recovery through a density gradient and sperm survival after a 24-hour incubation is predictive of IUI success in couples with male factor or unexplained infertility. MATERIALS AND METHODS Patient Population Patients who were candidates for IUI for either male factor or unexplained infertility at Bellingham IVF and Infertility Center from November 1994 through November 1997 were included in the study. Inclusion criteria included the following: [1] female age 36 years or younger; [2] documented patent tubes by either hysterosalpingogram or laparoscopy; [3] documented ovulatory cycles with adequate luteal phases either naturally or with clomiphene citrate (no gonadotropin stimulated cycles were included in the study); and [4] men had to have a minimum of processed total motile sperm. Couples were placed into two groups: those with male factor infertility or with unexplained infertility. The men in the male factor group had either a sperm concentration of /ml, overall motility of 50%, or sperm morphology of 30% by World Health Organization (WHO) criteria (8), or a combination of these abnormalities. The men in the unexplained infertility group had normal semen analysis by these criteria. Informed consent was obtained from all subjects, and the study protocol was approved by the institutional review board of Bellingham IVF and Infertility Center. Advanced Semen Analysis An advanced semen analysis was obtained from all couples within 2 6 weeks before starting IUIs. Before collecting the semen sample, men were instructed to abstain from ejaculation for 2 5 days. Samples were obtained by masturbation in a sterile specimen container (Baxter Hospital Supply, Deerfield, IL). The specimens were allowed to liquefy, and a standard WHO (8) criteria semen analysis was performed for semen volume, sperm concentration, motility, sperm morphology, and seminal leukocytes. A discontinuous two-layered Percoll gradient (40% 80%) Percoll (Sigma Chemical Company, St. Louis, MO) was set up in two blue-capped conical Falcon tubes (Baxter Hospital Supply). Beginning in January 1997, Isolate (Irvine Scientific, Santa Ana, CA) was used in place of Percoll. The samples were centrifuged at 350 g for 15 minutes. The supernatant was removed from each tube, and the pellets were combined with 2 ml of sperm wash (0.5% human albumin 100 in human tubal fluid medium, both from Irvine Scientific) and centrifuged at 250 g for 8 minutes. The supernatant was removed, and another wash with 2 ml of sperm wash medium at 250 g for 5 minutes was performed. The final pellet was resuspended in 2 ml of sperm wash medium. A sperm count and assessment of sperm motility was performed. The specimen concentration was adjusted to a maximum of motile sperm per milliliter of medium and incubated for 24 hours at 37 C in 5% CO 2 ; the percentage of sperm motility was reevaluated 24 hours later. All findings were recorded. Intrauterine Insemination Cycles All insemination cycles were monitored in the follicular phase with use of transvaginal ultrasound (Siemens Sonoline SL mHz transducer [Siemens Medical Systems, Issaquah, WA]) beginning on cycle days and repeated as needed. When the mean diameter of the lead follicle was 18 mm, 10,000 IU hcg was given IM, and a single IUI was performed hours later. The same sperm preparation as the Advanced Semen Analysis was used with Percoll before January 1997 and Isolate after. The sperm pellet was resuspended in 0.4 ml of sperm wash medium and drawn into an insemination catheter (Tomcat, Provet [Sherwood Medical, St. Louis, MO]) and then deposited high in the fundus of the uterus. The patient remained supine for 15 minutes after IUI. Serum hcg levels were drawn to confirm pregnancies, and 7-week gestation ultrasounds confirmed clinical pregnancies. Statistical Analysis 2 analysis was used to compare clinical pregnancy rates (PRs) with the various basic semen analysis parameters and the advanced semen analysis parameters. Linear regression analysis was used to correlate sperm recovered through the density gradient and 24-hour sperm survival with clinical PRs. Receiver operating characteristic curve analysis was used to generate cutoff values for processed sperm counts and 24-hour survival and to determine the predictive power of various sperm parameters. Sensitivity, specificity, and predictive values for positive and negative tests were calculated from these cutoff values. RESULTS Four hundred fourteen couples completed 1,160 IUI cycles (mean, 2.8 cycles; range, 1 9 cycles). The female age range was from 21 years to 36 years (mean, 33.1 years). The overall PR for all couples was 172 of 414 for a 41.5% rate, and the per cycle PR was 172 of 1,160 or 14.8%. Eighty-two percent (339 of 414) of the men in the study was in the male 548 Branigan et al. Screening test for IUI success Vol. 71, No. 3, March 1999
3 TABLE 1 Distribution of processed total motile sperm counts and 24-hour sperm survival. No. of sperm recovered ( 10 6 ) Processed total motile sperm No. of men with indicated sperm count/total number of men (%) Pregnancy rate per cycle (%) 5 33/414 (7.9) /414 (9.4) /414 (82.6) 16.9* Motility (%) 24-Hour sperm survival No. of men with indicated motility/total number of men (%) Pregnancy rate per cycle (%) /414 (36) /414 (16) /414 (48) 21.4* * P.001 versus other groups by 2 analysis. factor group, and 48% (164 of 339) of them was able to produce a pregnancy. In the unexplained infertility group (8 of 75), only 10% did. No significant relationships were found between PRs and any of the basic semen analysis parameters of concentration, motility, or morphology by 2 analysis using WHO values for normal and abnormal. The receiver operating characteristic analysis was also unable to predict IUI success from individual semen parameters. The distribution of processed total motile sperm counts and 24-hour sperm survival from the advanced semen analysis and their associated PR are shown in Table 1. Linear regression analysis showed a strong positive correlation between processed total motile counts and PR (r 0.78; P.001) and between 24-hour sperm survival and PR (r 0.89; P.001). Significant differences in the PR were noted only in the processed total motile counts of and 24-hour survival of 70%. Receiver operating characteristic curves suggested cutoff values for total counts of and 24-hour sperm survival of 70% or more. Using the processed total motile count of alone was not helpful in predicting those likely to benefit from IUIs because 82.8% of men were above this level. Significant differences in PR were seen only below level by 2 analysis. Processed total motile sperm count is most useful in setting a lower limit of (we had no pregnancies below this level) and an optimum level of or greater. The sperm survival test, however, was highly predictive. When the survival was 70%, 89% (162 of 182) of the couples became pregnant with a 21.4% (162 of 757) per cycle PR and accounted for 92% of all the pregnancies in the study. If the survival was 70%, the per cycle PR was 2.8% (11 of 403), and the cumulative PR was only 4.7%. Of the men with 70% survival, more than a third (38%) had survivals of 20%, and their per cycle PR was 2.7%. This poor sperm survival could not be predicted by any semen parameter. The cutoff values of processed total motile sperm and 24-hour sperm survival of 70% together were used to calculate the sensitivity, specificity, and predictive values of positive and negative tests for the advanced semen analysis. Sensitivity was 94% (162 of %) with a specificity of 86% (208 of %). The predictive value of a positive test was 83% (162 of %), and the predictive value for a negative test was 95% (208 of %). We also compared men with normal semen analysis (unexplained infertility) with those with abnormal ones (male factor). Twenty-three percent of men with a normal semen analysis failed to meet either one or both of the advanced semen analysis cutoff values. The advanced semen analysis is predictive, independent of whether the basic semen parameters are normal or abnormal. DISCUSSION These data show that the combination of number of motile sperm available for insemination and their 24-hour survival are highly predictive of IUI success. Twenty-fourhour sperm survival appears to be an especially important sperm characteristic for insemination success. The advanced semen analysis, which measures both of these sperm qualities, would make an excellent screening test to predict those likely to benefit from IUI. The test is easy to perform, requires no specialized laboratory equipment, is cost-effective, and accurately predicts those who could benefit from IUI in men with high sensitivity and specificity. In this study we found that none of the basic semen parameters of concentration, motility, or morphology was related to IUI success. Although processed total motile sperm showed an excellent correlation with PR, it did not screen out many men, because most (83%) had counts of 10 million. Huang et al. (6) found similar results using total motile counts, where PRs remained constant after motile sperm were reached. Men with the most severe sperm problems can be identified by the basic semen analysis parameters and are not candidates for IUIs. We did not have any pregnancies with processed total motile counts of , although others have reported pregnancies with lower counts. Our data suggest that processed total motile sperm is important only when it is below this threshold. Twenty-four-hour sperm survival is a sperm characteristic FERTILITY & STERILITY 549
4 that is not usually tested. Marked differences in sperm survival were noted when reporting the results of standard hamster sperm penetration assays. This sperm function test requires a 24-hour sperm incubation to allow capacitation and acrosome reaction to take place before placing the sperm with the hamster oocytes. A clinical observation that men with poor sperm survival did poorly in inseminations led to the idea for this study. Embryologists frequently observe this differential sperm survival when performing fertilization checks in IVF. Two studies have looked at sperm survival and IVF success. Fuse (9) looked at sperm survival in oligospermic men at several time intervals from 6 to 48 hours of incubation in men doing IVF. He found that if the sperm survived at all after 36 hours, there was a significant difference in fertilization rates in those surviving versus those that did not. Stovall et al. (10) looked at swim-up total motile sperm and 24-hour sperm survival to predict IVF success. They concluded that the number of sperm recovered after swim-up and the percentage that maintain their motility after 24 hours were both helpful in assessing IVF success. No studies have looked at sperm survival with respect to IUI. Sperm survival should be more important in IUIs than in IVF. The amount of time that the sperm need to be functional for the IUI would be much longer than IVF because of the highly variable time period between insemination and oocyte release. In IVF the sperm are placed directly on the oocyte and can be removed in 1 2 hours without affecting fertilization rate. In our program men who had poor overnight motility and who failed to conceive with IUIs have done well in IVF with average or above average fertilization and PRs (unpublished data). This study did not include any cycles in which superovulation was used. Several studies (11 13) showed that the use of gonadotropins is an independent variable that usually improves IUI per cycle PRs by increasing the number of fertilizable oocytes. However, because women have variable responses to gonadotropins, this would introduce another variable into the IUI success. Our goal was to isolate sperm parameters as the only variable for success. We achieved high per cycle PR without the multiple gestation risk, ovarian hyperstimulation, and expense of gonadotropin therapy. In our practice we use the same sperm preparation, ultrasound monitoring, hcg timing, and insemination technique for our therapeutic donor insemination (TDI) cycles (unpublished data). We have a 19.7% per cycle PR in our TDI cycles. This is not statistically significant compared with the 21.3% per cycle PR we achieved in those with 10 million processed total motile sperm and 70% 24-hour survival in the advanced semen analysis. Several studies concluded that IUI is not an effective treatment in subfertile men (14 17). Eighty-three percent of our couples had male factor problems as defined by one, two, or three abnormalities by WHO standards in their basic semen analysis parameters. They had a per cycle PR of 17.8% and a 48% cumulative PR. Twenty-three percent of men with completely normal semen parameters did not meet the cutoff values for 24-hour motility or processed total motile sperm. Their per cycle PR was 1.8%. The advanced semen analysis accurately predicted these occult male factors. This study used only one type of sperm preparation, insemination technique, and follicular monitoring technique for insemination timing. We were able to define clear cutoff values for IUI success. Other programs will need to confirm these findings. Different sperm preparations, such as washed and swim-ups, may yield different results. The advanced semen analysis in our hands is an effective screening tool for IUI success. In conclusion, our study suggests that recovery of processed sperm and their overnight survival would make an excellent screening test in the evaluation of couples considering IUI. References 1. Brasch JG, Rawlins R, Tarchala S, Radwanska E. The relationship between total motile sperm count and the success of intrauterine insemination. Fertil Steril 1994;62: Dimarzo SJ, Kennedy JF, Young PE, Herbert SA, Rosenburg DC, Villaneuva B. Effect of controlled ovarian hyperstimulation on pregnancy rates in intrauterine insemination. Am J Obstet Gynecol 1992; 166: Allen NC, Herbert CM III, Maxson WS, Rogers BJ, Diamond MP, Wentz AC. Intrauterine insemination: a critical review. Fertil Steril 1985;44: Francavilla F, Romano R, Santucci R, Poccia G. Effect of sperm morphology and motile sperm count on outcome of intrauterine insemination in oligozoospermia and/or asthenozoospermia. Fertil Steril 1990;53: Kerin JFP, Peek J, Warnes GM, Kirby C, Jeffrey R, Matthews CD, et al. Improved conception rates after intrauterine insemination of washed spermatozoa from men with poor quality semen. Lancet 1994;310: Huang HY, Lee CL, Lai YM, Chang MY, Wang HS, Chang SY, et al. The impact of the total motile count on the success of intrauterine insemination with husband s spermatozoa. J Assist Reprod Genet 1996; 13: Hoing LM, Devroey P, Van Steirteghem AC. Treatment of infertility because of oligo-astheno-teratozoospermia by transcervical intrauterine insemination of motile spermatozoa. Fertil Steril 1986;45: World Health Organization. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 3rd ed. New York: Cambridge University Press, 1992: Fuse M. Sperm survival test assessing the change of sperm motility after long-term incubation. Nippon Sanka Fujinka Gakkar Zasski 1990; 42: Stovall DW, Guzick DS, Berga SL, Krasnow JS, Zeleznick AJ. Sperm recovery and survival: two tests that predict in vitro fertilization outcome. Fertil Steril 1994;62: Dodson WC, Haney AF. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertil Steril 1991; 55: Bachus KE, Walmer DK. Superovulation and washed intra-uterine insemination. Contemp Obstet Gynecol 1992; Cruz RI, Kemmann E, Brandeis VT, Becker KA, Beck M, Beardsley M, et al. A prospective study of intrauterine insemination of processed sperm from men with oligoasthenospermia in superovulated women. Fertil Steril 1986;46: Ho P-C, Poon IML, Chan SYW, Wang C. Intrauterine insemination is not useful in oligoasthenospermia. Fertil Steril 1989;51: Kirby CA, Flakerty SP, Godfrey DM, Warnes GM, Matthews CD. A prospective trial of intrauterine insemination of motile spermatozoa verses timed intercourse. Fertil Steril 1991;56: Martinez AR, Benardus RE, Voorhorst FJ, Vermeiden JPW, Schoe- 550 Branigan et al. Screening test for IUI success Vol. 71, No. 3, March 1999
5 maker J. Intrauterine insemination does and clomiphene citrate does not improve fecundity in couples with infertility due to male or idiopathic factors: a prospective, randomized controlled study. Fertil Steril 1990; 53: Ho P-C, So W-K, Chan Y-F, Yeung WS-B. Intrauterine insemination after ovarian stimulation as a treatment for subfertility because of subnormal semen: a prospective randomized controlled trial. Fertil Steril 1992;58: FERTILITY & STERILITY 551
The relationship between total motile sperm count and the success of intrauterine insemination
FERTILITY AND STERILITY Copyright e 1994 The American Fertility Society Vol. 62. No.1. July 1994 Printed on acid-free paper in U. S. A. The relationship between total motile sperm count and the success
More informationVincent M.S. Lee*, Joycelyn S.Y. Wong, Sheila K.E. Loh, Noel K.Y. Leong
BJOG: an International Journal of Obstetrics and Gynaecology February 2002, Vol. 109, pp. 115 120 Sperm motility in the semen analysis affects the outcome of superovulation intrauterine insemination in
More informationAssisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION
( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation
More informationLinda M. Chafi'kin, M.D. John C. Nulsen, M.D. Anthony A. Luciano, M.D. Deborah A. Metzger, Ph.D., M.D.t
FRTILITY AND STRILITY Copyright 1991 The American Fertility Society Vol. 55, No.2, February 1991 Printed on acid-free paper in U.S.A. A comparative analysis of the cycle fecundity rates associated with
More informationThe Effect of Patient and Semen Characteristics on Live Birth Rates Following Intrauterine Insemination: A Retrospective Study 1
Journal of Assisted Reproduction and Genetics. Vol. 17, No., 000 CLINICAL ASSISTED REPRODUCTION The Effect of Patient and Semen Characteristics on Live Birth Rates Following Intrauterine Insemination:
More informationComparison of the effectiveness of single intrauterine insemination (IUI) versus double IUI per cycle in infertile patients
FERTILITY AND STERILITY VOL. 80, NO. 3, SEPTEMBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Comparison of the effectiveness
More informationCLINICAL ASSISTED REPRODUCTION
Journal of Assisted Reproduction and Genetics, Vol. 17, No. 4. 2000 CLINICAL ASSISTED REPRODUCTION CLINICAL ASSISTED REPRODUCTION Effect of Clinical and Semen Characteristics on Efficacy of Ovulatory Stimulation
More informationComparison of single versus double intra uterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Pathak B. Int J Reprod Contracept Obstet Gynecol. 2017 Dec;6(12):5277-5281 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20175091
More informationORIGINAL ARTICLE ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES
ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES Asha Verma 1, Rekha Mulchandani 2, Nupur Lauria 3, Kusum Verma 4, Sunita Himani 5 HOW TO CITE THIS ARTICLE: Asha Verma, Rekha Mulchandani, Nupur
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationClinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal Subfertility: Is It Crucial Step prior to ART?
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2011, Article ID 160467, 4 pages doi:10.5402/2011/160467 Clinical Study Fallopian Tube Sperm Perfusion in Treatment of Nontubal
More informationEffect of semen characteristics on pregnancy rate following intrauterine insemination
127 ORIGINAL Effect of semen characteristics on pregnancy rate following intrauterine insemination Uranchimeg Dorjpurev, Akira Kuwahara, Yuya Yano, Tomoko Taniguchi, Yuri Yamamoto, Ayako Suto, Yu Tanaka,
More informationRichard P. Dickey, M.D., Ph.D.,* Roman Pyrzak, Ph.D.,* Peter Y. Lu, M.D.,* Steven N. Taylor, M.D.,* and Philip H. Rye, M.D.*
MALE FACTOR FERTILITY AND STERILITY VOL. 71, NO. 4, APRIL 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Comparison
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationDecoding the effect of time interval between hcg and IUI and sperm preparation and IUI
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Agrawal S et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):892-896 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180509
More informationEFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION
Acta Medica Mediterranea, 2018, 34: 883 EFFECTS OF SPERM MORPHOLOGY AND TOTAL MOTILE SPERMATOZOA NUMBER ON THE RATE OF PREGNANCY THROUGH ARTIFICIAL INSEMINATION XUAN-CHENG MAI, LEI DING, YONG-FANG XU,
More informationLow Dose hmg As a First choice for Ovarian Stimulation in IUI cycles
Low Dose hmg As a First choice for Ovarian Stimulation in IUI cycles aslan, M.D Department of Obstetrics & Gynecology, Cairo University Abstract Objective: to compare pregnancy rates following low dose
More informationRole of intrauterine tubo-peritoneal insemination and intrauterine insemination in the treatment of infertility
International Journal of Research in Medical Sciences Gupta D et al. Int J Res Med Sci. 2017 May;5(5):2057-2061 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171842
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationIntrauterine Insemination - FAQs Q. How Does Pregnancy Occur?
Published on: 8 Apr 2013 Intrauterine Insemination - FAQs Q. How Does Pregnancy Occur? A. The female reproductive system involves the uterus, ovaries, fallopian tubes, cervix and vagina. The female hormones,
More informationTreatment of refractory infertility by transcervical intrauterine insemination of washed spermatozoa
FERTILITY AND STERILITY Copyright c 1987 The American Fertility Society Printed in U.S.A. Treatment of refractory infertility by transcervical intrauterine insemination of washed spermatozoa William Byrd,
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationUse of donor semen in the treatment of
Use of donor semen in the treatment of male infertility Where is the evidence? Max H.J.M. Curfs Isala clinics Zwolle, The Netherlands Strength of evidence Systematic review Meta-analysis RCT 1A 1A 1B
More informationUnderstanding Infertility, Evaluations, and Treatment Options
Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly
More informationRecent Developments in Infertility Treatment
Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other
More informationChanel L. Bonds, MD; William E. Roudebush, PhD; and Bruce A. Lessey, MD, PhD
Original Research Sperm Motility Index and Intrauterine Insemination Pregnancy Outcomes Chanel L. Bonds, MD; William E. Roudebush, PhD; and Bruce A. Lessey, MD, PhD From the Department of OB/GYN, Greenville
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationOriginal Article. Fauzia HaqNawaz 1*, Saadia Virk 2, Tasleem Qadir 3, Saadia Imam 3, Javed Rizvi 2
Original Article Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles Fauzia HaqNawaz 1*, Saadia
More informationINTRAUTERINE INSEMINATION FOR CERVICAL AND MALE FACTOR WITHOUT SUPEROVULATION
INTRAUTERINE INSEMINATION FOR CERVICAL AND MALE FACTOR WITHOUT SUPEROVULATION J. H. CHECK A. BOLLENDORF M. ZACCARDO D. LURIE B. VETTER The University of Medicine and Dentistry of New Jersey, Robert Wood
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationMinimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility*
FERTILITY AND STERILITY Copyright :Q' 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Minimal stimulation achieves pregnancy rates comparable to human menopausal
More informationThe prognostic factors for pregnancy after gonadotropin-induced controlled ovarian stimulation therapy with intrauterine insemination cycles
Available online at www.medicinescience.org ORIGINAL RESEARCH Medicine Science International Medical Journal Medicine Science 2018; ( ): The prognostic factors for pregnancy after gonadotropin-induced
More informationDelayed timing of intrauterine insemination results in a significantly improved pregnancy rate in female partners of quadriplegic men
FERTILITY AND STERILITY VOL. 76, NO. 6, DECEMBER 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Delayed timing of
More informationFactors determining successful intrauterine insemination
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Sinha P et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):3887-3891 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174028
More informationMinimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S
Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S Record Status This is a critical abstract of an economic
More informationUnexplained Infertility
Unexplained Infertility Kaylen M. Silverberg, M.D. Thomas C. Vaughn, M.D. Texas Fertility Center Austin, Texas Introduction Infertility is generally defined as the inability to conceive following one year
More informationBleeding and spontaneous abortion after therapy for infertility
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bleeding and spontaneous
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationIndian Journal of Basic and Applied Medical Research; September 2015: Vol.-4, Issue- 4, P
Original article: To study post intrauterine insemination conception rate among infertile women with polyp and women with normal uterine endometrium cavity 1Dr. Archana Meena, 2 Dr. Renu Meena, 3 Dr. Kusum
More informationIs the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion
F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl
More informationSubfertility B Y A L I S O N, B E N A N D J O H N
Subfertility B Y A L I S O N, B E N A N D J O H N Contents Definition Causes Male Female Hx & Ex Investigations Treatment Definition Failure to conceive after a year of frequent, unprotected communion.
More informationControlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study
Human Reproduction vol.13 no.6 pp.1553 1558, 1998 Controlled ovarian hyperstimulation and intrauterine insemination for treating male subfertility: a controlled study Bernard J.Cohlen 1,3, Egbert R.te
More informationSperm Surface Antibodies: IUI vs. IVF Treatment
Research Article Sperm Surface Antibodies: IUI vs. IVF Treatment Afaf Felemban MD*, Seham M. Hassonah MD, Najla Felimban KD, Hadeel Alkhelb MD, Samar Hassan MD, Fahad Alsalman MD Department of Obstetrics
More informationAssessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated IUI cycles
Middle East Fertility Society Journal Vol. 9, No. 1, 2004 Copyright Middle East Fertility Society Assessment of the value of ultrasound monitoring and doubling of insemination in clomiphene citrate stimulated
More informationThe evidence for insemination versus intercourse or IVF
To inseminate or not: that s the question! The evidence for insemination versus intercourse or IVF B.Cohlen, Genk 2009 There are believers and non-believers Ovarian stimulation protocols (anti-oestrogens,
More informationChris Davies & Greg Handley
Chris Davies & Greg Handley Contents Definition Epidemiology Aetiology Conditions for pregnancy Female Infertility Male Infertility Shared infertility Treatment Definition Failure of a couple to conceive
More informationHuman sperm penetration assay as an indicator of sperm function in human in vitro fertilization
FERTILITY AND STERILITY Copyright., 1987 The American Fertility Society Vol. 48, No. 2, August 1987 Printed in U.S.A. Human sperm penetration assay as an indicator of sperm function in human in vitro fertilization
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationIntroduction to Intrauterine Insemination (IUI) Service
Introduction to Intrauterine Insemination (IUI) Service Assisted Reproductive Technology Unit The Chinese University of Hong Kong Prince of Wales Hospital 2017 Treatment Procedures IUI involves six main
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationClomiphene citrate monitoring for intrauterine insemination timing: a randomized trial
OVULATION INDUCTION Clomiphene citrate monitoring for intrauterine insemination timing: a randomized trial Vivian Lewis, M.D., a John Queenan Jr., M.D., a Kathleen Hoeger, M.D., a Joanne Stevens, R.N.,
More informationovarian hyperstimulation (COH) and intrauterine
No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild and women with unexplained infertility after controlled ovarian hyperstimulation
More information5/5/2010. Infertility FINANCIAL DISCLOSURE. Infertility Definition. Objectives. Normal Human Fertility. Normal Menstrual Cycle
Infertility FINANCIAL DISCLOSURE I HAVE NO FINANCIAL INTEREST IN ANY OF THE PRODUCTS MENTIONED IN MY PRESENTATION Bryan K. Rone, M.D. University of Kentucky Obstetrics and Gynecology I AM RECEIVING COMPENSATION
More informationTECHNIQUES AND INSTRUMENTATION
FERTILITY AND STERILITY VOL. 76, NO. 1, JULY 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. TECHNIQUES AND INSTRUMENTATION
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationPredictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome
Azadeh Pravin Patel et al Original Article 10.5005/jp-journals-10006-1404 Predictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome 1 Azadeh Pravin
More informationINFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN
INFERTILITY: DIAGNOSIS, WORKUP AND MANAGEMENT FOR THE COMMUNITY PHYSICIAN Caitlin Dunne, MD, FRCSC Clinical Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationMALE FACTOR. Preoperative semen analysis as a predictor of seminal improvement following varicocelectomy
FERTILITY AND STERILITY VOL. 75, NO. 1, JANUARY 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. MALE FACTOR Preoperative
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationApproach to ovulation induction and superovulation in women with a history of infertility. Anatte E. Karmon, MD
Approach to ovulation induction and superovulation in women with a history of infertility Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the
More informationInfertility: A Generalist s Perspective
Infertility: A Generalist s Perspective Learning Objectives Fertility and Lifestyle: Patient education Describe the basic infertility workup Basic treatment strategies unexplained Heather Huddleston, MD
More informationSubfertility & prognostic factors & intrauterine insemination
Subfertility & prognostic factors & intrauterine insemination N.Cem FIÇICIOĞLU, M.D., Ph.D. Professor and Director Department of Gynecology & Obstetrics and IVF Center Yeditepe University, School of Medicine
More informationWhich is the Best Protocol of Ovarian Stimulation Prior to Artificial Insemination by Donor
Journal of Reproduction & Contraception doi: 10.7669j.issn.1001-7844.2014.01.0041 2014 Mar.; 25(1):41-48 E-mail: randc_journal@163.com Which is the Best Protocol of Ovarian Stimulation Prior to Artificial
More informationAcupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection
Acupuncture Treatment For Infertile Women Undergoing Intracytoplasmic Sperm injection Sandra L. Emmons, MD Phillip Patton, MD Source: Medical Acupuncture, A Journal For Physicians By Physicians Spring
More informationHuman Spermatozoa Attach to Trypsin-treated Hamster Zonae Pellucidae but do not Undergo Acrosome Reactions
Hiroshima J. Med. Sci. Vol.44, No.2, 47~51, June, 1995 HIJM 44-8 47 Human Spermatozoa Attach to Trypsin-treated Hamster Zonae Pellucidae but do not Undergo Acrosome Reactions Masatoshi KUMAGAI, Katsunori
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationChapter 1. Chapter 2. Chapter 3
Summary To perform IUI some conditions are required. This includes 1) a certain amount of progressively motile spermatozoa, 2) the presence of ovulation, 3) the presence of functional fallopian tubes,
More informationUnexplained infertility Evidence based management
Unexplained infertility Evidence based management Dr Mark Hamilton Consultant Gynaecologist NHS Grampian/University of Aberdeen m.hamilton@abdn.ac.uk www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc
More informationInduction of the human sperm acrosome reaction by human oocytes*
FERTILITY AND STERILITY Copyright C> 1988 The American Fertility Society Vol. 50, No.6, December 1988 Printed in U.S.A. Induction of the human sperm acrosome reaction by human oocytes* Christopher J. De
More informationTHE CERVICAL FACTOR IN INFERTILITY: DIAGNOSIS AND TREATMENT
FERTILITY AND STERILITY Copyright ' 1977 The American Fertility Society Vol. 28, No. 12, December 1977 Printed in U.S.A. THE CERVICAL FACTOR IN INFERTILITY: DIAGNOSIS AND TREATMENT JOSEF Z. SCOT!" M.D.*
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationControlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hcg Administration Than Spontaneous LH Surge
Original Article Controlled Ovarian Hyperstimulation with Intrauterine Insemination Is More Successful After r-hcg Administration Than Spontaneous LH Surge Evan Taerk, Edward Hughes, Cassandra Greenberg,
More informationARTIFICIAL INSEMINATION HOMOLOGOUS WITH OLIGOSPERMIC SEMEN SEPARATED ON ALBUMIN COLUMNS*
FERTILITY AND STERILITY Copyright 1979 The American Fertility SOciety Vol. 31, No. I, January 1979 Printed in V.SA. ARTIFICIAL INSEMINATION HOMOLOGOUS WITH OLIGOSPERMIC SEMEN SEPARATED ON ALBUMIN COLUMNS*
More informationIntrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates
Human Reproduction vol.15 no.3 pp.621625, 2000 Intrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates I.Ferrara 1, R.Balet 2 and J.G.Grudzinskas 1,2,3
More informationEVALUATING THE INFERTILE PATIENT-COUPLES. Stephen Thorn, MD
EVALUATING THE INFERTILE PATIENT-COUPLES Stephen Thorn, MD Overview The field of reproductive medicine continues to evolve rapidly by offering newer diagnostic testing and therapeutic options to improve
More informationPrediction of in vitro fertilization rates from semen variables
FERTILITY AND STERILITY Copyright il'1 1993 The American Fertility Society Printed on acid~ free paper in U.S.A. Prediction of in vitro fertilization rates from semen variables William W. Duncan Mary J.
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness Gerli S, Casini M L, Unfer V, Costabile L, Bini V,
More informationUvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication
UvA-DARE (Digital Academic Repository) Intrauterine insemination: Fine-tuning a treatment Custers, I.M. Link to publication Citation for published version (APA): Custers, I. M. (013). Intrauterine insemination:
More informationFred K. Kirchner, M.D.t B. Jane Rogers, Ph.D.*:j:
FERTILITY AND STERILITY Copyright c 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Establishment of TEST -yolk buffer enhanced sperm penetration assay limits for fertile males
More informationREPRODUCTIVE ENDOCRINOLOGY
REPRODUCTIVE ENDOCRINOLOGY FERTILITY AND STERILITY VOL. 81, NO. 5, MAY 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Analysis
More informationSetting The setting was secondary care. The economic study was carried out in Turkey.
Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination Baysoy A, Serdaroglu H, Jamal H, Karatekeli E, Ozornek H, Attar E Record Status This is a critical abstract
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationIntrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)
Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group POLICY DOCUMENT Intrauterine (IUI) and Donor Insemination
More informationMale subfertility and assisted reproduction: the quest for the ultimate treatment strategy van Weert, J-M.
UvA-DARE (Digital Academic Repository) Male subfertility and assisted reproduction: the quest for the ultimate treatment strategy van Weert, J-M. Link to publication Citation for published version (APA):
More informationPalm Beach Obstetrics & Gynecology, PA
Palm Beach Obstetrics & Gynecology, PA 4671 S Congress Avenue 4631 N Congress Avenue Lake Worth, FL 33461 West Palm Beach, FL 33407 INSTRUCTIONS FOR INFERTILITY WORKUP Please read these handouts carefully.
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.017.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2016
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.017.MH Infertility- Diagnosis This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationThe predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization
More informationNaProTechnology. An Integrated Approach to Infertility. Tracy Parnell. Geneva 2005
NaProTechnology An Integrated Approach to Infertility Tracy Parnell Geneva 2005 Outline Scientific foundations Illustrative case history Research Discussion and questions NPT Natural Procreative Technology(NPT)
More informationCihat Unlu*, M.D. Batuhan Ozmen**, M.D. Ankara, Turkey. Comment by:
4. Van Voorhis BJ, Barnett M, Sparks AE, Syrop CH, Rosenthal G, Dawson J. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization.
More information